• Mashup Score: 6

    According to Regeneron, the approval was based on data in the PULSAR and PHOTON trials, in which the drug demonstrated clinically equivalent vision gains to aflibercept Injection 2 mg that were maintained with fewer injections.

    Tweet Tweets with this article
    • BREAKING NEWS: Regeneron Pharmaceuticals announced the FDA has approved aflibercept injection 8 mg for the treatment of patients with wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy. #Retina #FDA #OphthTimes https://t.co/3V0NQxc3KB

  • Mashup Score: 0

    In a news release, the CDC is urging that clinicians and patients immediately discontinue the use of EzriCare Artificial Tears until the epidemiological investigation and laboratory analyses are complete.

    Tweet Tweets with this article
    • BREAKING NEWS: @CDCgov is urging that clinicians and patients immediately discontinue the use of EzriCare Artificial Tears until the epidemiological investigation and laboratory analyses are complete. #OphthTimes #Ophthalmology https://t.co/E1bOqTUD6Y

  • Mashup Score: 0

    Scientists from the Clear Vision Research Lab at The Australian National University and the Korean biotech company MDimune Inc. hope to turn recent research milestones into potential treatments for AMD.

    Tweet Tweets with this article
    • Scientists from the Clear Vision Research Lab at The Australian National University and the Korean biotech company MDimune Inc. hope to turn recent research milestones into potential treatments for AMD. #Ophthalmology #OphthTimes https://t.co/Kz91IeSJlO

  • Mashup Score: 1

    The ocular biomarkers studied showed poor to moderate accuracy for detecting the 2 disorders.

    Tweet Tweets with this article
    • European investigators led by Eliana Costanzo, MD, reported that more work needs to be done to identify ocular biomarkers of early Alzheimer’s disease mild cognitive impairment. #Ophthalmology #OphthTimes https://t.co/0M9lGwDjqQ